TrialClinIQ | $150,000 | (Apr 29, 2026)
Lighthouse Pharmaceuticals | $12,000,000 | (Apr 29, 2026)
Windmill(US) | $12,000,000 | (Apr 29, 2026)
dehaze
Germany
- Munich
- 29/04/2026
- Seed
- $3,746,192
dehaze is committed to uncover chronic diseases early enough to avoid negative quality of life impact on the patients.
Our proprietary AI helps identifying overlooked diagnoses, inappropriate treatments and future health risks.
We do this in a 3-step approach:
(1) We unify and harmonize patient data into clean health trajectories.
(2) We leverage our peer-reviewed AI model to identify outliers in the past trajectory and deviations in the future
(3) We proactively share the insights with clinicians and patients alike to act promptly.
- Industry Health and Human Services
- Website https://www.dehaze.de/
- LinkedIn https://www.linkedin.com/company/dehazeai/
Related People
Andreas SantoroCo Founder
Germany -
Stadt Hamburg, Hamburg
Ich bringe komplexe Gesundheitsdaten zum Sprechen.
Als CTO bei dehaze baue ich die technische Infrastruktur für unseren AI-Copiloten, der Ärzten hilft, das zu sehen, was im Datendschungel untergeht.
Das Problem: 30% der chronischen Krankheiten werden zu spät erkannt – weil Ärzte nur ~3% der verfügbaren Patientendaten reviewen können.
Unsere Lösung: KI, die den Rest analysiert und Risiken frühzeitig erkennt.
Wenn ich nicht am HealthPod baue: Zeit mit der Familie, Angeln, Espresso.
💬 Let's talk: DigitalHealth, AI in der Medizin, Tech Leadership
Golden Child | $37,000,000 | (Apr 29, 2026)
Clarasight | $11,500,000 | (Apr 29, 2026)
TriFetch | $1,900,000 | (Apr 28, 2026)
Linexa | $2,342,840 | (Apr 28, 2026)
HrFlow.ai | $7,000,000 | (Apr 28, 2026)